European growth private equity firm Keensight Capital has appointed David Piccoli as a Senior Analyst.
Piccoli has over three years of experience in private-equity investing within Europe, and has developed a particularly strong expertise in the healthcare sector.
He began his career in 2013 as an analyst within the Healthcare team of the 3i group and actively helped this team to become independent from the 3i group, a process which established a new entity, the investment fund ArchiMed. As a founding member of the ArchiMed team, he worked for 2 years as Senior Analyst, and had specific responsibilities for covering the Italian market within his role.
Piccoli, 27, is a graduate of ESCP Europe and has a Master’s degree in finance from London City University. Of Italian origin, he has worked in London, Paris and Milan, and speaks Italian, French, English and Spanish.
